PELVIPHARM

LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) - a summary of nonclinical studies. ESSM 2024 (Oral presentation). The post F. GIULIANO, D. GORNY, M. RAZANAKOLONA, D. BEHR-ROUSSEL, R. ASSALY, C. GAUFFIN

KH-001 delays para-chloroamphetamine-induced ejaculation in anaesthetized rat. JSM, 2026, 23(4), qdag044. The post PFEIFFER T, GERICKE N, RAZANAKOLONA M, BEHR-ROUSSEL D, BRACCONI M, GIULIANO F, PROTZKO R. appeared first on PELVIPHARM.

KH-001 delays para-chloroamphetamine-induced ejaculation in anaesthetized rat. Pfeiffer T, Gericke N, Razanakolona M, Behr-Roussel D, Bracconi M, Giuliano F, Protzko R. JSM, 2026, 23 (4), qdag044 Premature ejaculation remains a frequent male sexual dysfun

Pelvipharm and Vella Bioscience Inc present new findings on the Relaxant Effects of Cannabidiol on myometrium at the ISSWSH Meeting in Long Beach, USA, February 12 - 15, 2026. Harin Padma-Nathan will present a digital poster (#161) during an unmoderated p

Pelvipharm extends its warmest wishes to our valued clients, partners, and collaborators as we embark on this promising new year. May this new year bring you health, happiness and continued success. We look forward to collaborating with you and embracing

Pelvipharm and Otrera Medical Inc present new findings on the Relaxant Effects of Cannabidiol in Rats at the ISSWSH Meeting in Atlanta, USA, February 27 - March 2, 2025. Harin Padma-Nathan will present a digital poster during the poster session entitled "

As we step into 2025, the Pelvipharm SAS team extends its heartfelt gratitude to all our collaborators, partners, and clients. Thank you for making 2024 an exceptional year! Your trust and support have been the cornerstone of our achievements. Looking for

Presentation at the Congress of the ICS 2024 (International Continence Society) in Madrid, Spain, 23-25 October, 2024 reports new Viral Vector HSV1 Efficacy Studies in urology. Julien Ratelade from EG427 presented the results of a project performed in col

EG110A, a novel non-replicative HSV1-derived vector expressing the light chain of botulinum toxin F, shows dose-dependent efficacy in an acute intravesical capsaicin rat model. 2024 Oct - Continence ICS 2024 - Best in Category Prize: Research Methods / Te

LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) - a summary of nonclinical studies. ESSM 2024 (Bari, Italy, Oral presentation). The J. Sex. Med. - 2024 Nov. Volume 19, Issue 11, Suppl. 4, Page S3. The p